Jef Feeley, BNN Bloomberg

Jef Feeley

BNN Bloomberg

Contact Jef

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • BNN Bloomberg

Past articles by Jef:

Twitter trial against Musk is halted to allow deal to close

A Delaware judge halted a court case against Elon Musk over his US$44 billion purchase of Twitter Inc., giving the parties more time to complete the deal. → Read More

Musk’s Twitter buyout challenged by Florida pension fund

Elon Musk’s US$44 billion buyout of Twitter was challenged in a lawsuit by a Florida pension fund. → Read More

J&J, Teva opioid trial may signal cost of drug maker accords

A California judge may soon provide a clearer picture of what it will cost drug makers including Johnson & Johnson and Teva Pharmaceutical Industries Ltd. to resolve liability for their role in the U.S. opioid epidemic. → Read More

VW doesn't have to face Prevent's US$750M antitrust suit

A Detroit judge ruled Volkswagen AG doesn’t have to face a $750 million lawsuit by a unit of parts supplier Prevent Group, who alleged the carmaker sought to strangle the firm’s business over a pricing dispute. → Read More

Boeing board let CEO mislead on 737 Max crash causes, suit says

Boeing Co. directors, including current Chief Executive Officer David Calhoun, lied about the company’s oversight of its 737 Max 8 airliner and participated in a misleading public-relations campaign following two fatal crashes involving the plane, shareholders claim.The board ignored red flags about the 737 Max, didn’t develop its own tools to evaluate safety and didn’t properly hold former… → Read More

McKinsey agrees to US$550M opioid-claim settlement

McKinsey & Co. has agreed to pay more than US$550 million to settle claims by U.S. states that the consulting company helped fuel the opioid epidemic by providing marketing advice to drugmakers including Purdue Pharma LP and Johnson & Johnson, people familiar with the accord said. → Read More

U.S. sues Walmart over opioid sales, claiming it fueled crisis

The U.S. government accused Walmart Inc. of ignoring federal rules on opioid sales, saying in a federal lawsuit that the company helped fuel a crisis by turning a blind eye to suspicious prescriptions. → Read More

Walmart sues U.S. to fend off DOJ claims it mishandled opioids

Walmart Inc. sued the federal government in hopes of pre-empting regulators’ claims the retailer added fuel to the U.S.’s opioid crisis by filling suspicious painkiller prescriptions across the country. → Read More

J&J to pay more than US$100M to end over 1,000 talc suits

Johnson & Johnson has agreed to pay more than $100 million to resolve over 1,000 lawsuits blaming its baby powder for causing cancer, in the first set of major settlements in four years of litigation, people with knowledge of the pacts said. → Read More

LVMH countersues Tiffany over cancelled US$16B buyout

LVMH countersued Tiffany & Co. over the French luxury goods giant’s move to back out of its $16 billion purchase of the iconic New York-based jeweler, saying Tiffany has mismanaged its business in the wake of the COVID-19 pandemic. → Read More

Tiffany's suit over cancelled LVMH buyout put on fast track

Tiffany & Co. persuaded a judge to fast-track its lawsuit claiming LVMH is relying on faulty legal pretexts to cancel a $16 billion buyout of the U.S. luxury jewelry store chain. → Read More

McDonald's got 'benefit' of CEO's severance deal, he says

Former McDonald’s Corp. Chief Executive Officer Steve Easterbrook said the restaurant chain shouldn’t be allowed to claw back US$37 million of stock grants in his severance because the company got the “benefit of the bargain” in negotiating his departure. → Read More

LVMH-Tiffany busted deal is year's biggest to end up in court

Tiffany & Co. is suing to force LVMH to go through with its $16 billion acquisition, while LVMH said Thursday it would sue Tiffany to get out of it, in the latest broken deal to wind up in court. → Read More

Bayer extends CEO Baumann's contract through April 2024

Bayer AG extended Chief Executive Officer Werner Baumann’s contract through April 2024, a vote of confidence in a leader who has overseen the acquisition of Monsanto and the wave of litigation it brought. → Read More

Bayer agrees to pay US$1.6B to settle U.S. Essure suits

Bayer AG agreed to pay $1.6 billion to resolve most of the allegations that its now-withdrawn Essure contraceptive device failed to prevent pregnancies and caused excessive bleeding and pelvic pain in some women. → Read More

Minus Musk, Tesla board gets court nod for SolarCity settlement

Tesla Inc. directors, with the notable exception of Chief Executive Officer Elon Musk, won court approval for a US$60 million settlement of derivative claims by shareholders who say they were defrauded when the electric vehicle maker acquired another Musk-affiliated company, SolarCity, for US$2 billion in 2016. → Read More

Bayer says it’s in talks to settle Essure contraceptive suits

Bayer AG is in talks to resolve thousands of lawsuits that claim its Essure contraception device failed to prevent pregnancy or injured women, company officials said. → Read More

Lord & Taylor, oldest U.S. department store, files bankruptcy

Lord & Taylor, known for its upscale fashions and extravagant holiday window displays, sought bankruptcy protection from creditors after a turnaround effort faltered amid the coronavirus pandemic.The oldest U.S. department store filed for Chapter 11 protection in Richmond, Virginia, on Sunday. The company, founded in Manhattan by two English immigrants in 1826, listed assets and liabilities of… → Read More

Houston Rockets owner sues insurer over COVID-19 claim denials

The Houston Rockets and billionaire owner Tilman Fertitta are suing their insurer for denying the National Basketball Association team’s bid to tap its business-interruption insurance policy over revenue losses from the Covid-19 pandemic. → Read More

Bayer to retool plan for resolving future Roundup cancer suits

Bayer AG’s plan to address future Roundup cancer lawsuits as part of a nearly US$11 billion partial settlement has been temporarily pulled after a judge raised questions about whether it would pass legal muster. → Read More